• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胚系 RECQL 突变与乳腺癌易感性相关。

Germline RECQL mutations are associated with breast cancer susceptibility.

机构信息

Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.

1] Department of Human Genetics, McGill University, Montréal, Québec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.

出版信息

Nat Genet. 2015 Jun;47(6):643-6. doi: 10.1038/ng.3284. Epub 2015 Apr 27.

DOI:10.1038/ng.3284
PMID:25915596
Abstract

Several moderate- and high-risk breast cancer susceptibility genes have been discovered, but more are likely to exist. To discover new breast cancer susceptibility genes, we used 2 populations (from Poland and Quebec, Canada) and applied whole-exome sequencing in a discovery phase (n = 195), followed by validation. We identified rare recurrent RECQL mutations in each population. In Quebec, 7 of 1,013 higher-risk breast cancer cases and 1 of 7,136 newborns carried the c.634C>T (p.Arg215*) variant (P = 0.00004). In Poland, 30 of 13,136 unselected breast cancer cases and 2 of 4,702 controls carried the c.1667_1667+3delAGTA (p.K555delinsMYKLIHYSFR) variant (P = 0.008). RECQL is implicated in resolving stalled DNA replication forks to prevent double-stranded DNA (dsDNA) breaks. This function is related to that of other known breast cancer susceptibility genes, many of which are involved in repairing dsDNA breaks. We conclude that RECQL is a breast cancer susceptibility gene.

摘要

已经发现了一些中高危乳腺癌易感基因,但可能还有更多的基因存在。为了发现新的乳腺癌易感基因,我们使用了两个群体(来自波兰和加拿大魁北克),在发现阶段(n=195)进行了全外显子组测序,然后进行了验证。我们在每个群体中都发现了罕见的 RECQL 突变的反复出现。在魁北克,1013 名高危乳腺癌病例中有 7 名和 7136 名新生儿中有 1 名携带 c.634C>T(p.Arg215*)变异(P=0.00004)。在波兰,在 13136 名未经选择的乳腺癌病例中有 30 名和在 4702 名对照中有 2 名携带 c.1667_1667+3delAGTA(p.K555delinsMYKLIHYSFR)变异(P=0.008)。RECQL 参与解决停滞的 DNA 复制叉,以防止双链 DNA(dsDNA)断裂。该功能与其他已知的乳腺癌易感基因的功能相关,其中许多基因参与修复 dsDNA 断裂。我们得出结论,RECQL 是一个乳腺癌易感基因。

相似文献

1
Germline RECQL mutations are associated with breast cancer susceptibility.胚系 RECQL 突变与乳腺癌易感性相关。
Nat Genet. 2015 Jun;47(6):643-6. doi: 10.1038/ng.3284. Epub 2015 Apr 27.
2
Clinical implications of germline mutations in breast cancer genes: RECQL.胚系乳腺癌基因 RECQL 突变的临床意义
Breast Cancer Res Treat. 2019 Apr;174(3):553-560. doi: 10.1007/s10549-018-05096-6. Epub 2019 Jan 4.
3
Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.RECQL基因的突变与乳腺癌易感性相关。
PLoS Genet. 2015 May 6;11(5):e1005228. doi: 10.1371/journal.pgen.1005228. eCollection 2015 May.
4
FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.FANCM和RECQL基因变异与乳腺癌易感性:与波兰南部和乌克兰西部的相关性。
BMC Med Genet. 2018 Jan 19;19(1):12. doi: 10.1186/s12881-018-0524-x.
5
Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.RECQL 和 POLG 中的罕见错义突变与乳腺癌的遗传易感性相关。
Int J Cancer. 2018 Jun 1;142(11):2286-2292. doi: 10.1002/ijc.31259. Epub 2018 Jan 31.
6
Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.中欧乳腺癌患者及对照人群中RECQL剪接突变c.1667_1667+3delAGTA的分析
Fam Cancer. 2017 Apr;16(2):181-186. doi: 10.1007/s10689-016-9944-y.
7
RECQL: a new breast cancer susceptibility gene.RECQL:一种新的乳腺癌易感基因。
Cell Cycle. 2015;14(22):3540-3. doi: 10.1080/15384101.2015.1066539.
8
Germline RECQL mutations in high risk Chinese breast cancer patients.中国高危乳腺癌患者的生殖系RECQL基因突变
Breast Cancer Res Treat. 2016 Jun;157(2):211-215. doi: 10.1007/s10549-016-3784-1. Epub 2016 Apr 28.
9
RECQL: a DNA helicase in breast cancer.RECQL:一种与乳腺癌相关的DNA解旋酶。
Oncotarget. 2015 Sep 29;6(29):26558-9. doi: 10.18632/oncotarget.5452.
10
Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools.通过DNA池靶向新一代测序对卵巢癌患者的BARD1、PRDM9、RCC1和RECQL进行变异鉴定
Cancer Prev Res (Phila). 2022 Mar 1;15(3):151-160. doi: 10.1158/1940-6207.CAPR-21-0295.

引用本文的文献

1
Genetic Variants Associated with Breast Cancer Are Detected by Whole-Exome Sequencing in Vietnamese Patients.越南患者通过全外显子组测序检测出与乳腺癌相关的基因变异。
Diagnostics (Basel). 2025 Aug 28;15(17):2187. doi: 10.3390/diagnostics15172187.
2
Clinicopathological features of Chinese ovarian cancer patients with double heterozygosity for cancer-predisposed genes.中国癌症易感基因双杂合性卵巢癌患者的临床病理特征
BMC Cancer. 2025 Aug 28;25(1):1391. doi: 10.1186/s12885-025-14835-0.
3
Association analysis of germline mutations in CHEK2, PALB2, NBN and RECQL with the risk of ductal carcinoma in situ in Polish women.
CHEK2、PALB2、NBN和RECQL基因种系突变与波兰女性导管原位癌风险的关联分析
Hered Cancer Clin Pract. 2025 Aug 6;23(1):19. doi: 10.1186/s13053-025-00320-z.
4
Understanding how gene-disease relationships can impact clinical utility: adaptations and challenges in hereditary cancer testing.了解基因与疾病的关系如何影响临床应用:遗传性癌症检测中的调整与挑战。
Genome Med. 2025 Jul 1;17(1):73. doi: 10.1186/s13073-025-01499-5.
5
Detection rates of multigene panel and exome testing in patients with previous negative BRCA1/2 results.既往BRCA1/2检测结果为阴性的患者中多基因检测板和外显子组检测的检出率。
Fam Cancer. 2025 May 26;24(2):48. doi: 10.1007/s10689-025-00471-x.
6
Population-based study of recurrent DNA damage response gene variants in breast cancer cases.基于人群的乳腺癌病例中复发性DNA损伤反应基因变异的研究。
Breast Cancer Res Treat. 2025 May;211(1):195-202. doi: 10.1007/s10549-025-07634-5. Epub 2025 Feb 26.
7
The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population.主要为斯拉夫人种的国家中与疾病相关的等位基因谱。
Int J Mol Sci. 2024 Aug 28;25(17):9335. doi: 10.3390/ijms25179335.
8
The Impact of microRNA SNPs on Breast Cancer: Potential Biomarkers for Disease Detection.微小RNA单核苷酸多态性对乳腺癌的影响:疾病检测的潜在生物标志物
Mol Biotechnol. 2025 Mar;67(3):845-861. doi: 10.1007/s12033-024-01113-w. Epub 2024 Mar 21.
9
Characteristics of germline DNA damage response gene mutations in ovarian cancer in Southwest China.中国西南地区卵巢癌中胚系 DNA 损伤反应基因突变的特征。
Sci Rep. 2024 Mar 20;14(1):6702. doi: 10.1038/s41598-024-52707-y.
10
Germline gene mutations in Chinese patients with breast cancer.中国乳腺癌患者的生殖系基因突变
Front Med (Lausanne). 2024 Feb 19;11:1366769. doi: 10.3389/fmed.2024.1366769. eCollection 2024.